BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2014931)

  • 1. Bambuterol: a new long acting bronchodilating prodrug.
    Vilsvik JS; Langaker O; Persson G; Ringdal N; Schaanning J; Kvelstad G; Svensson K; Holthe S; Soliman S
    Ann Allergy; 1991 Apr; 66(4):315-9. PubMed ID: 2014931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bambuterol: new preparation. Poorly demonstrated efficacy.
    Prescrire Int; 1999 Jun; 8(41):70-1. PubMed ID: 10558442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.
    Persson G; Gnosspelius Y; Anehus S
    Eur Respir J; 1988 Mar; 1(3):223-6. PubMed ID: 3384075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
    Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
    Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration.
    D'Alonzo GE; Smolensky MH; Feldman S; Gnosspelius Y; Karlsson K
    Chest; 1995 Feb; 107(2):406-12. PubMed ID: 7842769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
    Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
    Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
    Persson G; Baas A; Knight A; Larsen B; Olsson H
    Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bambuterol: clinical effects of different doses of a long-acting bronchodilator prodrug.
    Sandström T; Asander L; Clemmensen IH; Eklund G; Gnosspelius Y; Klarlund Pedersen B; Persson G; Ravn S; Rosenhall L; Weeke B
    Respiration; 1988; 53(1):31-6. PubMed ID: 3387689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bambuterol: clinical effects of three doses of bambuterol once daily in asthmatic patients.
    Clemmensen IH; Pedersen BK; Ravn S; Laursen LC; Weeke B
    Allergy; 1988 Nov; 43(8):573-6. PubMed ID: 3061311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bambuterol: dose response study of a new terbutaline prodrug in asthma.
    Holstein-Rathlou NH; Laursen LC; Madsen F; Svendsen UG; Gnosspelius Y; Weeke B
    Eur J Clin Pharmacol; 1986; 30(1):7-11. PubMed ID: 3519240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of oral tulobuterol on bronchial obstruction in asthmatic patients].
    Vergeret J; Taytard A
    Therapie; 1988; 43(1):21-4. PubMed ID: 3358248
    [No Abstract]   [Full Text] [Related]  

  • 13. Bambuterol: effective in nocturnal asthma.
    Petrie GR; Chookang JY; Hassan WU; Morrison JF; O'Reilly JF; Pearson SB; Shneerson JM; Tang OT; Ning AC; Turbitt ML
    Respir Med; 1993 Nov; 87(8):581-5. PubMed ID: 8290741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma. The Bambuterol Multicentre Study Group.
    Zarkovic JP; Marenk M; Valovirta E; Kuusela AL; Sandahl G; Persson B; Olsson H
    Pediatr Pulmonol; 2000 Jun; 29(6):424-9. PubMed ID: 10821722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma.
    Sitar DS; Aoki FY; Warren CP; Knight A; Grossman RF; Alexander M; Soliman S
    Chest; 1993 Mar; 103(3):771-6. PubMed ID: 8449067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bambuterol: effects of a new anti-asthmatic drug.
    Pedersen BK; Laursen LC; Gnosspelius Y; Faurschou P; Weeke B
    Eur J Clin Pharmacol; 1985; 29(4):425-7. PubMed ID: 3912186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients.
    Wolfe JD; Tashkin DP; Calvarese B; Simmons M
    N Engl J Med; 1978 Feb; 298(7):363-7. PubMed ID: 340945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
    Gunn SD; Ayres JG; McConchie SM
    Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.
    Laursen LC; Taudorf E; Gnosspelius Y; Gymose E; Weeke B
    Eur J Respir Dis; 1985 Feb; 66(2):82-90. PubMed ID: 2578971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.